Total trials
41
Active
5
Phase 3
9
Total enrollment
46,958
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Yellow Fever vaccination | — | — | — | — | — | 1 | |
| BCG (Bacillus Calmette-Guérin) vaccine | — | — | — | — | — | 1 | |
| Lenacapavir long-acting | — | — | — | — | — | 1 | |
| Tenofovi-Emtricitabine (TDF/FTC) | — | — | — | — | — | 1 | |
| Doxycycline | — | — | — | — | — | 1 | |
| Oral Pre-Exposure Prophylaxis | — | — | — | — | — | 1 |
Next readouts
- 2018-12
- 2023-07-31
- 2026-12
- 2027-10
- 2029-02
Top conditions
- HIV Infections5
- Schistosomiasis3
- Hepatitis C3
- Tuberculosis3
- Pregnancy2
- Liver Diseases2
- HIV Infection2
- Sepsis2
Frequently asked questions about Oswaldo Cruz Foundation
- How many clinical trials does Oswaldo Cruz Foundation have on ClinicalTrials.gov?
- Oswaldo Cruz Foundation is listed as the lead sponsor on 41 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Oswaldo Cruz Foundation's trials are in Phase 3?
- 9 of Oswaldo Cruz Foundation's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does Oswaldo Cruz Foundation focus on?
- Oswaldo Cruz Foundation's most-studied conditions on ClinicalTrials.gov are HIV Infections, Schistosomiasis, Hepatitis C, Tuberculosis, Pregnancy.
- When are Oswaldo Cruz Foundation's next clinical trial readouts?
- Oswaldo Cruz Foundation has 5 upcoming primary-completion readouts tracked here; the soonest is “Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals”, expected around 2018-12.